<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>Seroprevalence of Toxocara spp Among Epileptic Patients in Iraq/Basra</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">BanAnas Sabbar</mods:namePart><mods:namePart type="family">BanAnas Sabbar</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Assim Khalid Assim</mods:namePart><mods:namePart type="family">Assim Khalid Assim</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Nadham Kadham Mahdi</mods:namePart><mods:namePart type="family">Nadham Kadham Mahdi</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>To study seroprevalence of Toxocara antibody Immunoglobulin G (IgG) and epidemiological risk factors as well as assessment the immunological pattern including cytokines, interleukin-6 (IL6) and interleukin-10 (IL-10) and immunoglobulin E (IgE) among epileptic patients in Basra province</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2024-02-16</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>